Cardinal Health: Vice President of Emerging Therapies
Fran Gregory, PharmD, MBA has been named Vice President of Emerging Therapies for Cardinal Health.
In this role, she will be responsible for responsible for cell & gene therapies and biosimilars.
“Fran began her career initiating one of the largest specialty pharmacies in the country. She followed that accomplishment with bringing the first cell & gene therapy in the world to patients.
“Most recently, Fran developed and launched several of the most successful biosimilars in the US. She has a passion for complex, life-changing medicines and excels at developing and growing innovative business units. Fran is an industry expert in reimbursement, value-based pharmaceutical contracting, HEOR, and leading successful teams.”
